Home › Funds › UBS Group AG › IMPLQ
UBS Group AG position in IMPLQ
IMPEL PHARMACEUTICALS INC
Latest position (Q3 2023)1.45K sh
Reported value held$621
Portfolio Weight0.00%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 6.53K | $80.00K | New |
| Q4 2021 | 15.67K | $135.00K | Add |
| Q1 2022 | 1.96K | $13.00K | Reduce |
| Q2 2022 | 1.31K | $12.00K | Reduce |
| Q3 2022 | 1.31K | $6.00K | Hold |
| Q4 2022 | 1.74K | $6.54K | Add |
| Q1 2023 | 1.31K | $1.83K | Reduce |
| Q2 2023 | 1.31K | $1.66K | Hold |
| Q3 2023 | 1.45K | $621 | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding IMPLQ
No other tracked fund reports a position in IMPLQ.